Developments Actinogen, FDA agree on activities toward marketing approval of Xanamem for AD Actinogen Medical (ASX: ACW) has announced that an agreement with the FDA has been reached in a scheduled Type C meeting on the manufacturing, clinical, and nonclinical activities required for a future US marketing... September 16, 2025